gms | German Medical Science

22nd Annual Meeting of the German Retina Society

German Retina Society

26.06. - 27.06.2009, Berlin

Guidelines for diagnosis and treatment of diabetic retinopathy in Germany

Meeting Abstract

Search Medline for

  • Klaus D. Lemmen - Eye Department of the St. Martinus Hospital Düsseldorf

German Retina Society. 22nd Annual Meeting of the German Retina Society. Berlin, 26.-27.06.2009. Düsseldorf: German Medical Science GMS Publishing House; 2009. DocRG2009-07

doi: 10.3205/09rg07, urn:nbn:de:0183-09rg075

This is the English version of the article.
The German version can be found at: http://www.egms.de/de/meetings/rg2009/09rg07.shtml

Published: June 29, 2009

© 2009 Lemmen.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Guidelines of the German Diabetes Association (DDG)

Diagnosis, therapy and follow up of diabetic retinopathy and diabetic macular edema

http://www.deutsche-diabetes-gesellschaft.de/redaktion/mitteilungen/leitlinien/leitlinien_der_DDG_Updates.php

Contents:

Recommendations for diagnosis and treatment of diabetic retinopathy and diabetic macular edema for patients with with Type 1 and Type 2 diabetes, including:

1.
Epidemiology
2.
Pathogenetic factors and pathophysiology
3.
Clinical picture
4.
Diagnostic techniques and follow up intervals
5.
Diabetologic therapy (blood glucose control, arterial hypertension, hyperlipidemia, medical therapy of diabetic retinopathy)
6.
Ophthalmologic therapy (laser photocoagulation, vitrectomy)

The available information materials are:

Expert’s Guidelines-Version Update 03/2004 [1]

Practical Guidelines-Version Update 05/2007 [2]

National Standard of Care Guideline Diabetes Type 2: „Prevention and Therapy of retinal complications with Diabetes Type 2“

of the “Ärztliche Zentrum für Qualität in der Medizin”, Berlin, with “Bundesärztekammer, Kassenärztliche Bundesvereinigung” and the “Arbeitsgemeinschaft wissenschaftlich-medizinischer Fachgesellschaften” [3]

http://www.diabetes.versorgungsleitlinien.de

Contents:

Recommendations and guidelines for diabetic retinopathy und macular edema with Type 2 Diabetes, including:

1.
Definition, targets und epidemiology
2.
Symptoms, risk factors and prognosis
3.
General targets for treatment and prevention
4.
Follow up intervals
5.
Therapy
6.
Management of care and coordination
7.
Audit

The available information materials are:

Long version “NVL Typ-2-Diabetes - Thema Netzhaut-Komplikationen (2nd edition, Update 04/2008)”

Short version “NVL Typ-2-Diabetes -Thema Netzhaut-Komplikationen (nd. edition, Update 04/2008)”

Pocket guidelines Version “NVL Typ-2-Diabetes-Thema Netzhaut-Komplikationen (2nd edition, Version 09/2007)”, 2-page overview

Patient version “NVL Typ-2-Diabetes - Thema Netzhautkomplikationen” (2nd edition, Version 03/2009)


References

1.
Hammes HP, Bertram B, Bornfeld N, Danne D, Kroll P, Lemmen KD. „Diagnostik, Therapie und Verlaufskontrolle der diabetischen Retinopathie und Makulopathie“ November 2004. Scherbaum WA, Kiess, W (Hrsg.): Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft (DDG). http://www.deutsche-diabetes-gesellschaft.de/leitlinien/EBL_Retinopathie_Update_2004.pdf External link
2.
Hammes HP, Lemmen KD. „Diabetische Retinopathie und Makulopathie“. In: Scherbaum WA (Hrsg.): Praxis-Leitlinien der Deutschen Diabetes-Gesellschaft (DDG). Diabetologie und Stoffwechsel 2008, Band 3, Supplement 2, S 147-150.
3.
Nationale Versorgungs-Leitlinie Typ-2-Diabetes „Prävention und Therapie von Netzhautkomplikationen (Klinisch relevante Auszüge aus der Leitlinie)“. Dtsch Ärztebl 2007 104(4): A-211 / B-191 / C-187.